Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
about
Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionA Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle.Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article.Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.Efficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study
P2860
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
@en
type
label
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
@en
prefLabel
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
@en
P2860
P356
P1476
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
@en
P2093
Myeong Jun Song
P2860
P304
P356
10.3748/WJG.V21.I13.3843
P407
P577
2015-04-01T00:00:00Z